New anti-cancer therapy: Converting glioma cells into neurons
Credit: Jinan University Glioma is a fatal neurological disorder that has limited interventional treatment, despite extensive research over the past ...
Tag: cancer
Increasing diversity in clinical trials the focus of new stand up to cancer team
The Health Equity Breakthrough Team includes clinical cancer specialists and experts in the social science components of community healthCredit: Stand ...
Planting the seed for DNA nanoconstructs that grow to the micron scale
A concept for seeded all-or-nothing assembly of micron-scale DNA nanostructures that could extend nanofabrication capabilities and enable creation of highly ...
Detonating fuse for breast cancer discovered
Credit: Birchmeier Lab, MDC Breast cancer is the most common type of tumour found in women. 69,000 new cases are ...
Oncotarget: Hispanic Chronic myelomonocytic leukemia patients
This Oncotarget study had significantly lower mutation rates in ASXL1 and SETBP1, and a higher rate of muTET2/wtASXL1Credit: Correspondence to ...
Oncotarget: Predictors of immunotherapy benefit in Merkel cell carcinoma
Dr. Glenn J. Hanna from CCR/NCI in Bethesda, MD as well as The Dana-Farber Cancer Institute in Boston Massachusetts said, ...
Oncotarget: Ibuprofen disrupts protein complex in colorectal cells
The Oncotarget data shed new light on the biochemical mechanisms behind ibuprofen's action on alternative spliced RAC1B and may support ...
Deluge of DNA changes drives progression of fatal melanomas
Credit: WEHI, Australia Melbourne researchers have revealed how melanoma cells are flooded with DNA changes as this skin cancer progresses ...
Majority of cancer patients with COVID-19 have similar immune response to people without cancer
New study finds most people with cancer should be prioritized for COVID-19 vaccinationsCredit: Albert Einstein College of Medicine March 22, ...
Hormone drugs may disarm COVID-19 spike protein and stop disease progression
A new Penn Medicine study shows how anti-androgen drugs disrupt key receptors required for viral invasion of cellsCredit: Getty Images ...
LSU Veterinary School receives $11M COBRE grant for a pre-clinical cancer research center
Credit: LSU The Louisiana State University School of Veterinary Medicine, or LSU SVM, has received an $11 million grant to ...
City of Hope celebrates earning one of nursing’s highest honors
The prestigious Magnet® recognition from the American Nurses Credentialing Center highlights City of Hope's world-class nursing team and their superior ...
First-in-human phase I trial to assess the efficacy and safety of a novel Myc inhibitor
Peptomyc's Omomyc-based therapy against cancer put to the clinical testCredit: VHIO Co-founded back in 2014 by VHIO's Laura Soucek, CEO ...
CU cancer researcher wins two awards to study drug-resistant cancer cells
University of Colorado Boulder researcher Sabrina L. Spencer, PhD., recently won the Damon Runyon-Rachleff Innovation Award (from the Damon Runyon ...
Maintaining body weight won’t save colorectal cancer survivors
Stable body weight may hide loss of muscle, 40 percent higher risk of premature deathCredit: Pennington Biomedical Research Center Colorectal ...
Starving tumors by blocking glutamine uptake
Credit: Sanford Burnham Prebys Medical Discovery Institute LA JOLLA, CALIF. - March 19, 2021 - Scientists at Sanford Burnham Prebys ...
Oncotarget: Quantitative proteome profiling stratifies fibroepithelial lesions of the breast
The present Oncotarget work shed light on a brief mechanistic framework of PTs aggressive nature and present potential biomarkers to ...
ATRT molecular groups: looking at the biology from the clinic
Scientists at St. Jude Children's Research Hospital are learning more about what the molecular groups of a rare pediatric brain ...
New cancer-fighting immunotherapy enters clinical trials
Credit: von Brünneck / Charité - Joint press release by the MDC and Charité - A new cancer-fighting gene therapy ...
Durvalumab immunotherapy proceeds to phase 3 trial for malignant pleural mesothelioma
After phase 2 trials showed promising survival for the combination of durvalumab and standard chemotherapy, collaborators in the US, Australia, ...
